Younger age at diagnosis, Clark level II linked to low risk for death among patients with stage I lesions, negative clinical nodes.
Current evidence is insufficient for assessing balance of benefits and harms of screening for asymptomatic teens, adults.
A single-center review of cases sought to identify the risk factors for temporal facial nerve damage in patients with skin cancer undergoing Mohs micrographic surgery.
The optimal sequence of treatment for BRAF-mutant melanoma is nivolumab-ipilimumab followed by dabrafenib-trametinib, a study suggests.
Two-year overall survival higher for those initiating treatment with combo nivolumab/ipilimumab versus dual BRAF/MEK inhibition.